CA Prop 65

-2- Proposition 65 List of Chemicals
4-Aminobiphenyl (4-amino-
cancer
92-67-1
February 27, 1987
diphenyl)
1-Amino-2,4-dibromo-
cancer
81-49-2
August 26, 1997
anthraquinone
3-Amino-9-ethylcarbazole
cancer
6109-97-3
July 1, 1989
hydrochloride
2-Aminofluorene
cancer
153-78-6
January 29, 1999
Aminoglutethimide
developmental
125-84-8
July 1, 1990
Aminoglycosides
developmental
---
October 1, 1992
1-Amino-2-methylanthraquinone
cancer
82-28-0
October 1, 1989
2-Amino-5-(5-nitro-2-furyl)-1,3,4-
cancer
712-68-5
July 1, 1987
thiadiazole
4-Amino-2-nitrophenol
cancer
119-34-6
January 29, 1999
Aminopterin
developmental, female
54-62-6
July 1, 1987
Amiodarone hydrochloride
developmental, female,
19774-82-4
August 26, 1997
male
Amitraz
developmental
33089-61-1
March 30, 1999
Amitrole
cancer
61-82-5
July 1, 1987
Amoxapine
developmental
14028-44-5
May 15, 1998
Amsacrine
cancer
51264-14-3
August 7, 2009
tert-Amyl methyl ether
developmental
994-05-8
December 18, 2009
Delisted December 13, 2013
Anabolic steroids
female, male
---
April 1, 1990
Analgesic mixtures containing
cancer
---
February 27, 1987
phenacetin
Androstenedione
cancer
63-05-8
May 3, 2011
Angiotensin converting enzyme
developmental
---
October 1, 1992
(ACE) inhibitors
Aniline
cancer
62-53-3
January 1, 1990
Aniline hydrochloride
cancer
142-04-1
May 15, 1998
o-Anisidine
cancer
90-04-0
July 1, 1987
o-Anisidine hydrochloride
cancer
134-29-2
July 1, 1987
Anisindione
developmental
117-37-3
October 1, 1992
Anthraquinone
cancer
84-65-1
September 28, 2007
Antimony oxide (Antimony trioxide)
cancer
1309-64-4
October 1, 1990
Aramite
cancer
140-57-8
July 1, 1987
Areca nut
cancer
---
February 3, 2006
Aristolochic acids
cancer
---
July 9, 2004
Arsenic (inorganic arsenic
cancer
--
February 27, 1987
compounds)
Arsenic (inorganic oxides)
developmental
---
May 1, 1997
Asbestos
cancer
1332-21-4
February 27, 1987
Aspirin (NOTE: It is especially
developmental, female
50-78-2
July 1, 1990
important not to use aspirin
during the last three months of
pregnancy, unless specifically
directed to do so by a physician
because it may cause problems
in the unborn child or
complications during delivery.)
Atenolol
developmental
29122-68-7
August 26, 1997
Atrazine
developmental, female
1912-24-9
July 15, 2016
Auramine
cancer
492-80-8
July 1, 1987
Auranofin
developmental
34031-32-8
January 29, 1999
Avermectin B1 (Abamectin)
developmental
71751-41-2
December 3, 2010
Azacitidine
cancer
320-67-2
January 1, 1992
Azaserine
cancer
115-02-6
July 1, 1987